# US 2025/0152530 A1 · Sotalol hydrochloride dosing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152530 A1
- Document ID: US20250152530A1
- Status: Published application
- Kind: A1
- Application number: 19/022,878
- Filed: 2025-01-15
- Published: 2025-05-15
- Earliest claimed: 2018-08-14
- Assignees: AltaThera Pharmaceuticals LLC
- Applicants: AltaThera Pharmaceuticals LLC
- Inventors: John Charin Somberg; Brandon Ira Kashfian; Janos Molnar
- Web page: https://patentgrep.com/patent/US20250152530A1

## CPC

- A61K 31/18: Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N- group A61K31/63)
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61P 9/06: Antiarrhythmics
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides novel methods of administering sotalol hydrochloride to patients in need thereof.

## Claims

### Claim 1

A method of administering sotalol hydrochloride, comprising:
a. administering a single intravenous (IV) dose of 55-125 mg sotalol hydrochloride over a period of 1 hour to a subject having had symptomatic atrial fibrillation or atrial flutter, wherein the subject is currently in sinus rhythm; and
b. after completion of the IV dose, administering oral dosing of one or more oral dose of sotalol hydrochloride to the subject in an amount of 80 mg or 120 mg.

### Claim 2 (depends on 1)

The method of claim 1, wherein the oral dosing is initiated 4-12 hours after completion of the IV dose.

### Claim 3 (depends on 1)

The method of claim 1, wherein:
the IV dose is 55-85 mg sotalol hydrochloride; and
the oral dosing comprises administering one or more oral dose in the amount of 80 mg.

### Claim 4 (depends on 1)

The method of claim 1, wherein:
the IV dose is 75-115 mg sotalol hydrochloride; and
the oral dosing comprises administering one or more oral dose in the amount of 120 mg.

### Claim 5 (depends on 3)

The method of claim 3, wherein the oral dosing is initiated 4-12 hours after completion of the IV dose.

### Claim 6 (depends on 5)

The method of claim 5, wherein one or more of the oral doses are administered at a 12-48 hour interval from initiation of the oral dosing.

### Claim 7 (depends on 6)

The method of claim 6, wherein:
the oral dosing is initiated 4-6 hours after completion of the IV dose; and
one or more of the oral doses are administered at a 12-24 hour interval from initiation of the oral dosing.

### Claim 8 (depends on 6)

The method of claim 6, wherein:
the oral dosing is initiated 6-12 hours after completion of the IV dose; and
one or more of the oral doses are administered at a 24-48 hour interval from initiation of the oral dosing.

### Claim 9 (depends on 4)

The method of claim 4, wherein the oral dosing is initiated 4-12 hours after completion of the IV dose.

### Claim 10 (depends on 9)

The method of claim 9, wherein one or more of the oral doses are administered at a 12-48 hour interval from initiation of the oral dosing.

### Claim 11 (depends on 10)

The method of claim 10, wherein:
the oral dosing is initiated 4-6 hours after completion of the IV dose; and
one or more of the oral doses are administered at a 12-24 hour interval from initiation of the oral dosing.

### Claim 12 (depends on 10)

The method of claim 10, wherein:
the oral dosing is initiated 6-12 hours after completion of the IV dose; and
one or more of the oral doses are administered at a 24-48 hour interval from initiation of the oral dosing.

### Claim 13 (depends on 1)

The method of claim 1, wherein the subject is naïve to sotalol prior to administering the single IV dose of sotalol hydrochloride.

### Claim 14 (depends on 1)

The method of claim 1, wherein:
the administering of the single IV dose of sotalol hydrochloride comprises escalating the subject to a higher oral dosage; and
one or more of the oral doses comprise 120 mg sotalol hydrochloride.

### Claim 15 (depends on 3)

The method of claim 3, wherein:
the single IV dose comprises 60-85 mg sotalol hydrochloride; and
one or more of the oral doses comprise 80 mg sotalol hydrochloride.

### Claim 16 (depends on 1)

The method of claim 1, wherein:
the single IV dose comprises 82-113 mg sotalol hydrochloride; and
one or more of the oral doses comprise 80 mg or 120 mg sotalol hydrochloride.

### Claim 17 (depends on 16)

The method of claim 16, wherein the oral dosing is administered at a 12-hour interval.

### Claim 18 (depends on 1)

The method of claim 1, wherein:
the subject has renal impairment;
the subject has a creatinine clearance in the range of 10-90 mL/min; and
the oral dosing is administered at a 12-hour interval.

### Claim 19 (depends on 18)

The method of claim 18, wherein:
the single IV dose comprises 70-125 mg sotalol hydrochloride.

### Claim 20 (depends on 19)

The method of claim 19, wherein the subject is naïve to sotalol.
